Wed, Apr 16, 2014, 3:03 AM EDT - U.S. Markets open in 6 hrs 27 mins

Recent

% | $
Quotes you view appear here for quick access.

Zalicus Inc. Message Board

zing21042 176 posts  |  Last Activity: 12 hours ago Member since: Dec 28, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Ocker..

    by iamafakker 14 hours ago
    zing21042 zing21042 12 hours ago Flag

    You should be safe but expect a bit more deterioration. The problems may escalate to global matters and away from a normal market correction. I am starting to worry about what the US is going to do militarily if Russia continues on this path with other regions proximal to its borders and heavily populated by Russian decedents. Could get messy for all, and real fast.

    Zing

  • Reply to

    Ocker..

    by iamafakker 14 hours ago
    zing21042 zing21042 12 hours ago Flag

    Stock,
    I guess you have now become a believer. Todays drop was uncharacteristically large and on good volume. If the market is to continue on this trend, expect things to start settling down when the NASDAQ gets to 3800-3900 +/- and the S&P at 1750-1780 +/-...not sure where that with put Kerx. As noted before, one can nibble a bit, but start look for the volumes on the down side to dry up and for trading to get mixed. Right now, the bears are in charge and they seem not to want to let go. If it breaks much below its current price, the next stop is at a triple bottom set around $12.30 +/-.

    Good luck
    Zing

  • Reply to

    tempted to nibble here

    by eranbob 15 hours ago
    zing21042 zing21042 13 hours ago Flag

    Eran,

    This was pretty much common knowledge...at least for those who have been around following this story from the beginning. Although this in and of itself is not a big problem for the company, it is one of the factors that in my opinion weighs heavily on the sale of the company or lack thereof. Those who think the company will be sold are somewhat delusional. This idea was left over from the perifosine days where the CEO made no bones about the fact that if the trials were successful he would actively pursue the sale of the company. However, since that drug failed, and as you point out the licensing of Zerenex, coupled with some still believing that the patents may not hold up in the long run, along with numerous other sticky points, it is unlikely that a sale is in the works or ever will be in the works. In the end, I would not concern myself with licensing of the drug. This is very common practice in the biotech/biopharmaceutical industry. Focus on the quality of the product and the potential market and you will be fine.

    Zing

  • zing21042 zing21042 15 hours ago Flag

    Duct,

    Got it! Sorry for the misunderstanding.

  • zing21042 zing21042 17 hours ago Flag

    Agreed, but this still has nothing to do with new information or a reason to expect a turn in share price. The percentage of lay press and analysts that attend these meetings is quite small...miniscule is a better descriptor. Anything that may strike them as "great information" or " new and exciting" remains old hat to investors, scientists and others in the know. As such, they are "non-events" except for those one in 10,000 appearances where new information surfaces at precisely the correct time to allow release and presentation at the meeting...it is easy to add this to a presentation even though it was not in the Abstact. Still, these are very rare events. If you do not believe me, follow the share price as the meeting approaches then ends. Remember these are scientific meetings, not meetings to entice investors or sway analysts.

    Zing

  • zing21042 zing21042 19 hours ago Flag

    Duct,

    I am not too clear as to all the whoopla that surrounds these meeting presentations; not just on this board but on most every board. In nearly every case, the data being presented is already out in the public domain; maybe not the complete analysis, but certainly the top and bottom line interpretations of the data. The abstracts may have been made publically available last week as you state, but the deadline for submitting these abstracts was back on Dec 2, 2013. So the data in the abstracts or associated with the presentations are a bare minimum of 5-6 months old and that is if and only if the data came out days before the abstract was written and submitted.

    Also, a company cannot hold material information regarding new trial data for longer than a few days so the thought that there will be this big announcement seems never to materialize. As a result, "great expectations" in the eyes of the shareholders are rarely if ever met so stock prices tend to suffer rather than benefit from these meetings. I see this in the CA field with the upcoming ASCO meetings...but the same scenario prevails; meetings this large usually have submission deadlines of at least 5-6 months in advance.

    Put another way, ask yourself, what it is that you are expecting to hear from the presentation on the safety profiles of the PII and PIII trials, or the Hgb data of the CRUISE trial that has not already been made available to you and to warrant such high expectations from the presentations?

    Zing

  • Reply to

    The purpose of an ASCO presentation?

    by posiedon59 Apr 14, 2014 9:38 AM
    zing21042 zing21042 Apr 14, 2014 11:52 AM Flag

    I never said that 'encouraging' results would not be presented; however to blindly assume that because an abstract is being presented at ASCO it must there be linked to "treatments that work" is simply incorrect.

    Also, I find it very hard to believe that what will be presented will be anything more than what we already know. Granted it may be accompanied by more detailed analyses, but I am not expecting any data that is not already in the public domain...unless it is preclinical information.

    Zing

  • Reply to

    The purpose of an ASCO presentation?

    by posiedon59 Apr 14, 2014 9:38 AM
    zing21042 zing21042 Apr 14, 2014 10:40 AM Flag

    It is done all the time ('presenting treatments that don't work'). If there is no avenue to present data from failed trials and experiments, what would prevent others from repeating the same mistakes? There is a big difference between negative data and failed experiments. Do you really think that the thousands of abstracts and presentations at ASCO are based upon success stories?

    When Thomas Edison was criticized for trying and failing nearly 2000 times to make the light bulb, he responded, "I did not fail 2000 times to make a light bulb, rather I learned 2000 ways NOT to make a light bulb." There is madness to the process of science and like it or not, failure is a big part of that process and dissemination of the information from those failures is equally important.

    Zing

  • Reply to

    Buy In Price

    by jda1942 Apr 10, 2014 11:57 AM
    zing21042 zing21042 Apr 11, 2014 7:49 AM Flag

    sorry jp, I do not purport to be a prognosticator of stock prices on the upside or the downside. The only thing I might look for given recent volatility and the magnitude of that volatility is a "healthy" 10% correction from the highs. If you believe the economy and the market are otherwise sound and that a major debacle like the bank crisis of 2008/9 is not forthcoming, and that recent North Korean and Russian aggression will not spoil things, a 10% market correction (not stock correction) or something in that range is well within possibility, and probably envisioned by many as necessary in order for us to move to new highs a bit later this year. The high beta stocks (biopharma/biotech/technology) tend to get hit the hardest at the outset.

    So, a 10% correction from the highs would put the S&P in the range of the Feb low at 1750-1780 +/- and the NASDAQ also in the range of the Feb low at 3900 +/-. Will they reach those levels?? Who knows; but we are heading into typically the slow investing months of the year ("Sell in May and don't return till Labor day") and in association with the recent market weakness, it is definitely doable in my opinion. If the market trends continue, this could mute the impact of the impending approval of Zerenex...it is simply too difficult a call. Remember also, sector "Leaders" do not end these sell offs, investors end them.

    JMHO
    Zing

  • Reply to

    Buy In Price

    by jda1942 Apr 10, 2014 11:57 AM
    zing21042 zing21042 Apr 10, 2014 4:59 PM Flag

    you and me both....but that being said, once the volume starts to slow up, I will start adding in small chunks, but adding nonetheless.

  • Reply to

    Buy In Price

    by jda1942 Apr 10, 2014 11:57 AM
    zing21042 zing21042 Apr 10, 2014 3:18 PM Flag

    It is indeed my opinion, but I am sure that when it was trading at $17+, the general sentiment was that it would never...ever... see the 14's again....well here we are. I learned one does not fight the tape. If one takes the emotion out of the trade, this stock will settle when the rest of the market settles and that right now is a mystery. But overall market conditions suggest that down is more likely than up at least over the short term. If the S$P does not hold 1780 +/-, it could get real ugly...for everyone. Good luck!!

    Zing

  • Reply to

    Spill Brains Out - A Question

    by bigjeff11709 Apr 9, 2014 4:07 PM
    zing21042 zing21042 Apr 10, 2014 10:22 AM Flag

    way to go!!! If you keep asking, you might end up buying a used car or a refrigerator from him.

  • Reply to

    Spill Brains Out - A Question

    by bigjeff11709 Apr 9, 2014 4:07 PM
    zing21042 zing21042 Apr 10, 2014 9:08 AM Flag

    Bigjeff,

    You simply need to put this person on ignore; I did after a very pointless conversation that made me conclude he is simply brain dead...there was no alternative explanation. He brings nothing to the table other than an opinion akin to that of a used car salesman (or maybe vacuum cleaners door-to-door ...not yet sure). When possible (if possible) he interprets data to his own liking and not at face value. He believes that Zerenex is almost as worthless as his commentary and in short, nothing will ever come of the drug. In all/any of his posts have you ever seen him waver from these points? More importantly, have you ever seen him post anything to substantiate his position other than to tout he is a salesman and that makes him omniscient? Do yourself a favor, be a trend setter and put this person on ignore unless of course you enjoy the unqualified banter and the frustration....then knock yourself out!!!

    Zing

  • zing21042 zing21042 Apr 9, 2014 11:03 AM Flag

    Agreed. This is the problem with people cutting and pasting...they put this stuff out their and want the reader to try and figure out what they just posted.

    Zing

  • zing21042 zing21042 Apr 9, 2014 10:11 AM Flag

    get it right #2; Iron in dialysate is not considered "IV iron"

  • Reply to

    well guys I almofst missed the buyout party!

    by waiting4kerx Apr 7, 2014 9:52 AM
    zing21042 zing21042 Apr 8, 2014 11:27 AM Flag

    Glad you are feeling better. 44? Wow. Did they provide a reason/cause?
    Zing

  • Reply to

    well guys I almofst missed the buyout party!

    by waiting4kerx Apr 7, 2014 9:52 AM
    zing21042 zing21042 Apr 8, 2014 6:46 AM Flag

    W4K,
    Here's hoping all is better. The concern is what did they attribute the clots to? Leg-derived deep vein thrombosis ? Trauma to the legs? Had you had any surgery of late? You on thinners currently? What is the prognosis?

    Best wishes,
    Zing

  • zing21042 zing21042 Apr 4, 2014 7:51 AM Flag

    Doc,

    First...prostrate is what some one does when they lay stretched out on the ground facing downward; prostate is a part of the body (but then again, you are the educated one here so you knew that).

    Second, inasmuch as you are so educated and intellectually above the masses, please provide us one and only one example, where a drug/biologic/etc. that is either currently approved and in use, or currently in trials, has been successfully used to treat each and everyone of the hundreds if not thousands of forms of CA? If you cannot....you have asked and answered your own question i.e. Now.... what was that about an uneducated baggie?

    Zing

  • Reply to

    how long for Triferic?

    by seth1611 Mar 25, 2014 5:03 PM
    zing21042 zing21042 Apr 1, 2014 5:59 AM Flag

    who is "jonzzzz"?

  • zing21042 zing21042 Mar 28, 2014 7:14 AM Flag

    I would not read too much into the acceptance of presentations i.e. abstracts. Data representing failed trials is also presented at such meetings. At this stage it is all data...it is all information that others may learn from. As such, I would not equate "acceptance of an abstract" as indicative of anything other than for what it is...the right to present clinical and/or preclinical data be it good, bad or ugly.

    Zing

ZLCS
1.03-0.06(-5.50%)Apr 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.